Pilot study on the feasibility of PET/CT lymphoscintigraphy with 89Zr-nanocolloidal albumin for sentinel node identification in oral cancer patients

Journal of Nuclear Medicine

Volumn 54, Issue 4, 2013, Pages 585-589

  Heuveling, Derrek A ^a   Van Schie, Annelies ^a   Vugts, Danielle J ^a   Hendrikse, N Harry ^a   Yaqub, Maqsood ^a   Hoekstra, Otto S ^a   Karagozoglu, K Hakki ^a   Leemans, C René ^a   Van Dongen, Guus A M S ^a   De Bree, Remco ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

89Zr; Head and neck cancer; Nanocoll; PET CT; Sentinel node

Indexed keywords

ALBUMIN TC 99M COLLOID; ALBUMIN ZR 89 COLLOID; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ARTICLE; CANCER STAGING; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; FEASIBILITY STUDY; GEL PERMEATION CHROMATOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE QUALITY; LYMPHOSCINTIGRAPHY; MOUTH CANCER; NECK DISSECTION; PILOT STUDY; PRIORITY JOURNAL; SENTINEL LYMPH NODE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

FEASIBILITY STUDIES; HUMANS; LYMPHATIC METASTASIS; LYMPHOSCINTIGRAPHY; MOUTH NEOPLASMS; NANOSTRUCTURES; NEOPLASM STAGING; PILOT PROJECTS; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOISOTOPES; TECHNETIUM TC 99M AGGREGATED ALBUMIN; ZIRCONIUM;

EID: 84875762304     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.112.115188     Document Type: Article

References (14)

1. Haerle SK, Hany TF, Strobel K, Sidler D, Stoeckli SJ. Is there additional value of SPECT/CT over planar lymphoscintigraphy for sentinel node mapping in oral/oropharyngeal squamous cell carcinoma? Ann Surg Oncol. 2009;16:3118-3124.
2. Hornstra MT, Alkureishi LWT, Ross GL, Shoaib T, Soutar DS. Predictive factors for failure to identify sentinel nodes in head and neck squamous cell carcinoma. Head Neck. 2008;30:858-862.
3. Shoaib T, Soutar DS, MacDonald DG, Gray HW, Ross GL. The nodal neck level of sentinel lymph nodes in mucosal head and neck cancer. Br J Plast Surg. 2005;58:790-794.
4. Alkureishi LWT, Ross GL, Shoaib T, et al. Sentinel node biopsy in head and neck squamous cell cancer: 5-year follow-up of a European multicenter trial. Ann Surg Oncol. 2010;17:2459-2464.
5. Heuveling DA, Visser GWM, Baclayon M, et al. 89Zr-nanocolloidal albuminbased PET/CT lymphoscintigraphy for sentinel node detection in head and neck cancer: preclinical results. J Nucl Med. 2011;52:1580-1584.
6. GE Healthcare. Summary of Product Characteristics: Nanocoll. Eindhoven, The Netherlands: GE Healthcare; August 2010.
7. Alkureishi LWT, Burak Z, Alvarez JA, et al. Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma. Eur J Nucl Med Mol Imaging. 2009;36:1915-1936.
8. Heuveling DA, Flach GB, Van Schie A, et al. Visualisation of the sentinel node in early stage oral cancer: limited value of late static lymphoscintigraphy. Nucl Med Commun. 2012;33:1065-1069.
9. Heuveling DA, Karagozoglu KH, Van Schie A, Van Weert S, Van Lingen A, De Bree R. Sentinel node biopsy using 3D lymphatic mapping by freehand SPECT in early stage oral cancer: a new technique. Clin Otolaryngol. 2012;37:89-90.
10. Robbins KT, Clayman G, Levine PA, et al. Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery. Arch Otolaryngol Head Neck Surg. 2002;128:751-758.
11. Heller S, Zanzonico P. Nuclear probes and intraoperative gamma cameras. Semin Nucl Med. 2011;41:166-181.
12. 99mTc-nanocolloid. Eur J Nucl Med Mol Imaging. 2012;39:1128-1136.
13. Heuveling DA, Visser GWM, De Groot M, et al. Nanocolloidal albumin-IRDye 800CW: a near-infrared fluorescent tracer with optimal retention in the sentinel lymph node. Eur J Nucl Med Mol Imaging. 2012;39:1161-1168.
14. Bredell MG. Sentinel lymph node mapping by indocyanin green fluorescence imaging in oropharyngeal cancer: preliminary experience. Head Neck Oncol. 2010;2:31.